Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Temsirolimus (Primary) ; Cisplatin; Cyclophosphamides; Doxorubicin; Etoposide; Irinotecan; Isotretinoin; Topotecan
- Indications Neuroblastoma
- Focus Adverse reactions
- 19 May 2010 Actual patient number (4) added as reported by ClinicalTrials.gov.
- 19 May 2010 Planned end date changed from 1 Dec 2012 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.